Biological behavior of human breast cancer micrometastases

Clinical Cancer Research

Volumn 7, Issue 8, 2001, Pages 2434-2439

  Klauber DeMore, N ^a   Van Zee, K J ^a   Linkov, I ^a   Borgen, P I ^a   Gerald, W L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOGENESIS; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST METASTASIS; CANCER DIAGNOSIS; CANCER RECURRENCE; CLINICAL ARTICLE; HUMAN; LYMPHADENECTOMY; PRIORITY JOURNAL; TUMOR GROWTH;

ADULT; AGED; APOPTOSIS; BREAST NEOPLASMS; CELL DIVISION; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; VON WILLEBRAND FACTOR;

EID: 0034890326     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Dormancy of mammary carcinoma after mastectomy
2. Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: Further support about the concept of tumor dormancy
3. Proposal for a new model of breast cancer metastatic development
4. Dormancy and breast cancer
5. Local recurrences following mastectomy: Support for the concept of tumor dormancy
6. Tumor angiogenesis
7. The experimental study of tumor progression. A review
8. An approach for the treatment of penile carcinoma
9. Technical details of intraoperative lymphatic mapping for early stage melanoma
10. Occult axillary lymph node metastases in "node-negative" breast carcinoma
11. Detection and significance of occult metastases in node-negative breast cancer
12. Occult axillary node metastases in breast cancer: Their detection and prognostic significance
13. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer
14. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: A preliminary study
15. Lessons learned from 500 cases of lymphatic mapping for breast cancer
16. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled (PAP) procedures
17. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
18. Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases
19. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
20. Breast
21. A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma
22. A Gompertzian model of human breast cancer growth
23. Evolving concepts in the systemic drug therapy of breast cancer
24. Predicting the course of Gompertzian growth
25. Tumor dormancy: Not so sleepy after all
26. Melanoma: Lessons from metastases
27. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
28. Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways
29. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: A potential role for T cells in angiogenesis
30. Tumor induction of VEGF promoter activity in stromal cells
31. Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression
32. Leukocyte-endothelial adhesion and angiogenesis in tumors
33. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
34. The biology of vascular endothelial growth factor
35. Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor
36. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
37. Tumor behavior in isolated perfused organs: In vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment
38. What is the evidence that tumors are angiogenesis dependent?
39. Polychemotherapy for early breast cancer: An overview of the randomized trials
40. Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and Taxol
41. The microtubule-affecting drug paclitaxel has antiangiogenic activity
42. Paclitaxel (Taxol): An inhibitor of angiogenesis in a highly vascularized transgenic breast cancer
43. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer